Contributions of 20-HETE to the antihypertensive effects of tempol in Dahl salt-sensitive rats

Hypertension

Volumn 41, Issue 3 II, 2003, Pages 697-702

  Hoagland, Kimberly M ^a   Maier, Kristopher G ^a   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Blood pressure; Cytochrome P450; Free radicals; Reactive oxygen species; Sodium; Superoxide

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ANTIOXIDANT; CREATININE; DRINKING WATER; FORMAMIDINE; ISOPROSTANE; N HYDROXY N' (4 BUTYL 2 METHYLPHENYL)FORMAMIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SUPEROXIDE; TEMPOL; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; BIOAVAILABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFECT; ENZYME INHIBITION; FEEDING; KIDNEY INJURY; MALE; MEAN ARTERIAL PRESSURE; MICROSOME; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; CYCLIC N-OXIDES; DINOPROST; F2-ISOPROSTANES; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; KIDNEY; MALE; NITRIC OXIDE; RATS; RATS, INBRED DAHL; SPIN LABELS; SUPEROXIDES;

EID: 0037342599     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000047881.15426.DC     Document Type: Conference Paper

References (37)

1. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 2001;37:541-546.
2. Dobrian AD, Schriver SD, Prewitt RL. Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension. 2001;38:361-366.
3. Nishiyama A, Fukui T, Fujisawa Y, Rahman M, Tian RX, Kimura S, and Abe Y. Systemic and regional hemodynamic responses to Tempol in angiotensin II-infused hypertensive rats. Hypertension. 2001;37:77-83.
4. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angtiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
5. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralcorticoid hypertension and renal inflammatory response. Hypertension. 2001;37:781-786.
6. Sommers MJ, Mavromatis K, Galis ZS, Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by DOCA-salt. Circulation. 2000;101:1722-1728.
7. Vaziri ND, Ding Y, Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension: reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther. 2001;298:679-685.
8. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematsu M, Zweifach BW, Schmid-Schonbein GW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A. 1998;95:4754-4759.
9. Suzuki H, Swei A, Zweifach BW, Schmid-Schonbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension. 1995;25:1083-1089.
10. Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the eudothelium. Hypertension. 1999;33:1353-1358.
11. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membranepermeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998;32:59-64.
12. Schnackenberg CG, Wilcox CS. Two-week administration of Tempol attenuates both hypertension and renal excretion of 8-isoprostaglandin F2α. Hypertension. 1999;33:424-428.
13. Meng S, Roberts LJ II, Cason GW, Curry TS, Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol. 2002;283:R732-R738.
14. Swei A, Lacy F, DeLano FA, Schmid-Schonbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension. 1997;30:1628-1633.
15. Swei A, Lacy F, DeLano FA, Parks DA, Schmid-Schonbein GW. A mechanism of oxygen free radical production in the Dahl hypertensive rat. Microcirculation. 1999;6:179-187.
16. Atarashi K, Ishiyama A, Takagi M, Minami M, Kimura K, Goto A, Omata M. Vitamin E ameliorates the renal injury of Dahl salt-sensitive rats. Am J Hypertens. 1997;10:116S-119S.
17. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension. 2000;36:142-146.
18. Makino A, Skelton MM, Zou A-P, Roman RJ, Cowley AW Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension. 2002;39:667-672.
19. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens. 1998;16:1267-1271.
20. Prabha PS, Das UN, Koratkar R, Sagar PS, Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot Essent Fatty Acids. 1990;41:27-33.
21. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension. 1999;33:83-89.
22. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:131-185.
23. Morrow JD, Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res. 1997;36:1-21.
24. Alonso-Galicia M, Sun CW, Falck JR, Harder DR, Roman RJ. Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. Am J Physiol. 1998;275:F370-F378.
25. Zou AP, Drummond HA, Roman RJ. Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension. 1996;27:631-635.
26. Alonso-Galicia M, Frohlich B, Roman RJ. Induction of P4504A activity improves pressure-natriuresis in Dahl S rats. Hypertension. 1998;31:232-236.
27. Ma YH, Schwartzman ML, Roman RJ. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol. 1994;267: R579-R589.
28. Maier KG, Henderson L, Narayanan J, Alonso-Galicia M, Falck JR, Roman RJ. Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid. Am J Physiol. 2000;279:H863-H871.
29. Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Ueki T, Sato M, Kameo K. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol. 2001;133:325-329.
30. Cowley AW Jr, Roman RJ, Kaldunski ML, Dumas P, Dickhout JG, Greene AS, Jacob HJ. Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat. Hypertension. 2001;37:456-461.
31. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension. 2001;37:547-553.
32. KM Hoagland, Maier KG, Godbert SL, Aebly MR, Flasch AK, Roman RJ. Effect of dietary salt on renal metabolism of arachidonic acid in inbred strains of rats. FASEB J. 2001;15:A147. Abstract.
33. Yuan B, Cowley AW Jr. Evidence that reduced renal medullary nitric oxide synthase activity of Dahl S rats enables small elevations of arginine vasopressin to produce sustained hypertension. Hypertension. 2001;37:524-528.
34. Szentivanyi M Jr, Zou AP, Mattson DL, Soares P, Moreno C, Roman RJ, Cowley AW Jr. Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am J Physiol. 2002;283: R266-R272.
35. Patel AR, Layne S, Watts D, Kirchner KA. L-Arginine administration normalizes pressure-natriuresis in hypertensive Dahl rats. Hypertension. 1993;22:863-869.
36. Miyata N, Zou AP, Mattson DL, Cowley AW Jr. Renal medullary interstitial infusion of L-arginine prevents hypertension in Dahl saltsensitive rats. Am J Physiol. 1998;275:R1667-R1673.
37. Szentivanyi M Jr, Zou AP, Maeda CY, Mattson DL, Cowley AW Jr. Increase in renal medullary nitric oxide synthase activity protects from norepinephrine-induced hypertension. Hypertension. 2000;35:418-423.